The Lancet Regional Health – Southeast Asia
-
1
[Articles] Incidence and mortality of invasive fungal infections among patients admitted in intensive care units in India: findings from a multicentric registry-based study (2023–25)
-
2
[Comment] India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation
-
3
[Correspondence] South Asia's cardiometabolic burden: exposomal determinants of a health transition
-
4
[Articles] Effects of prenatal early food and micronutrient supplementations on body size and cardiometabolic risk factors in the 15-year-old offspring – the MINIMat randomised trial
-
5
[Comment] Accurately estimating unmet transplant need is essential for planning equitable transplantation services
-
6
[Correspondence] Bhotekoshi flash flood in Nepal: healthcare on the frontline
-
7
[Articles] Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: a randomized controlled trial (2023)
-
8
[Articles] Soil-transmitted helminthiasis prevalence and infection intensity among school-going children in Timor-Leste after the prolonged interruption of deworming: a cross-sectional survey (2025)
-
9
[Articles] Iodine nutrition, thyroid function, and thyroid autoimmunity four decades after Universal Salt Iodisation in India: a cross-sectional study among schoolchildren (ICMR-SALT-T 1)
-
10
[Articles] Epidemiology of Kyasanur forest disease in India, 2000–2025: a systematic review and meta-analysis
The Lancet Regional Health – Western Pacific
-
1
[Viewpoint] “Indigenous models of social prescribing”–a six-domain framework for social wellbeing and other support services delivered by Aboriginal Community Controlled Health Organisations
-
2
[Comment] Reimagining healthcare in Indonesia for 2045: a Lancet Regional Health – Western Pacific Commission
-
3
[Articles] Tirofiban vs standard antiplatelet therapy in acute branch atheromatous disease-related stroke: a multicenter, randomized, open-label, blinded-endpoint, parallel-group, phase III clinical trial
-
4
[Articles] Burden of typhoid fever in primary and hospital care in Indonesia: a serial cross-sectional study using national health insurance (BPJS Kesehatan) data, 2015–2023
-
5
[Articles] Effect of statins on the mortality of long-term survivors of nasopharyngeal carcinoma: a population-based study in endemic area
-
6
[Articles] Trends and transition dynamics of heated tobacco product use in Japan, 2015–2025: a repeated cross-sectional and longitudinal study
-
7
[Articles] Trends and disparities in hepatitis B burden in the Western Pacific Region, 2015–2024: a subregional analysis using modelled data
-
8
[Articles] HBsAg seroclearance with HBV DNA <100 IU/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study
-
9
[Articles] The epidemiological impact and effectiveness of herpes zoster vaccination among older and pharmacologically immunocompromised adults: a population-based observational study
-
10
[Articles] Projections of diabetes mellitus in Japan through 2040: a bayesian age-period-cohort analysis of the national health and nutrition survey population